No interaction studies have been performed with REKOVELLE. With pituitary desensitisation caused by a GnRH agonist, a longer duration of stimulation and therefore a higher total dose of REKOVELLE may be necessary to achieve adequate follicular response. Clinically significant interactions with other medicinal products have neither been reported during REKOVELLE therapy nor are expected.